| Autor: |
Federici L; Department of Innovative Technologies in Medicine and Dentistry, University 'G. d' Annunzio', 66100 Chieti, Italy.; CAST (Center for Advanced Studies and Technology), University 'G. d' Annunzio', 66100 Chieti, Italy., Masulli M; Department of Innovative Technologies in Medicine and Dentistry, University 'G. d' Annunzio', 66100 Chieti, Italy., De Laurenzi V; Department of Innovative Technologies in Medicine and Dentistry, University 'G. d' Annunzio', 66100 Chieti, Italy.; CAST (Center for Advanced Studies and Technology), University 'G. d' Annunzio', 66100 Chieti, Italy., Allocati N; Department of Innovative Technologies in Medicine and Dentistry, University 'G. d' Annunzio', 66100 Chieti, Italy. |
| Abstrakt: |
Protein glutathionylation is a reversible post-translational modification that involves the attachment of glutathione to cysteine residues. It plays a role in the regulation of several cellular processes and protection against oxidative damage. Glutathionylation (GS-ylation) modulates protein function, inhibits or enhances enzymatic activity, maintains redox homeostasis, and shields several proteins from irreversible oxidative stress. Aberrant GS-ylation patterns are thus implicated in various diseases, particularly those associated with oxidative stress and inflammation, such as cardiovascular diseases, neurodegenerative disorders, cancer, and many others. Research in the recent years has highlighted the potential to manipulate protein GS-ylation for therapeutic purposes with strategies that imply both its enhancement and inhibition according to different cases. Moreover, it has become increasingly evident that monitoring the GS-ylation status of selected proteins offers diagnostic potential in different diseases. In this review, we try to summarize recent research in the field with a focus on our current understanding of the molecular mechanisms related to aberrant protein GS-ylation. |
